Sammita Satyanarayan

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The impact of relapse definition and measures of durability on MS clinical trial outcomes”.

The impact of relapse definition and measures of durability on MS clinical trial outcomes

Multiple Sclerosis Journal(2023)10.1177/13524585231157211

N/A

0.839DataRank · unranked

10 citations

Gary Cutter, Stephen Krieger, Stacey S. Cofield, Jerry S. Wolinsky, Fred Lublin +1 more

Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy

Multiple Sclerosis and Related Disorders(2022)10.1016/j.msard.2022.104486

N/A

0.416DataRank · unranked

15 citations

Sacha Gnjatic, Florian Krammer, Kevin Tuballes, Juan Manuel Carreño, Sammita Satyanarayan +16 more

Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis

Multiple Sclerosis and Related Disorders(2022)10.1016/j.msard.2022.103737

N/A

0DataRank · unranked

18 citations

Neha Safi, Tali Sorets, Susan Filomena, Yi-Nan Zhang, Sylvia Klineova +9 more